Logo image of WRD

WERIDE INC-ADR (WRD) Stock Fundamental Analysis

NASDAQ:WRD - Nasdaq - US9509151083 - ADR - Currency: USD

10.08  -0.18 (-1.75%)

After market: 9.95 -0.13 (-1.29%)

Fundamental Rating

3

WRD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. WRD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WRD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WRD has reported negative net income.
WRD had a negative operating cash flow in the past year.
WRD Yearly Net Income VS EBIT VS OCF VS FCFWRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

WRD has a Return On Assets of -32.71%. This is amonst the worse of the industry: WRD underperforms 92.59% of its industry peers.
Looking at the Return On Equity, with a value of -35.62%, WRD is doing worse than 87.65% of the companies in the same industry.
Industry RankSector Rank
ROA -32.71%
ROE -35.62%
ROIC N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRD Yearly ROA, ROE, ROICWRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

The Gross Margin of WRD (30.66%) is better than 88.89% of its industry peers.
WRD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for WRD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
WRD Yearly Profit, Operating, Gross MarginsWRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

WRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WRD has been increased compared to 1 year ago.
Compared to 1 year ago, WRD has a worse debt to assets ratio.
WRD Yearly Shares OutstandingWRD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M 250M
WRD Yearly Total Debt VS Total AssetsWRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 18.52 indicates that WRD is not in any danger for bankruptcy at the moment.
WRD has a Altman-Z score of 18.52. This is amongst the best in the industry. WRD outperforms 100.00% of its industry peers.
WRD has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
WRD's Debt to Equity ratio of 0.01 is amongst the best of the industry. WRD outperforms 92.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 18.52
ROIC/WACCN/A
WACC7.81%
WRD Yearly LT Debt VS Equity VS FCFWRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 13.43 indicates that WRD has no problem at all paying its short term obligations.
WRD has a Current ratio of 13.43. This is amongst the best in the industry. WRD outperforms 97.53% of its industry peers.
A Quick Ratio of 13.06 indicates that WRD has no problem at all paying its short term obligations.
WRD's Quick ratio of 13.06 is amongst the best of the industry. WRD outperforms 97.53% of its industry peers.
Industry RankSector Rank
Current Ratio 13.43
Quick Ratio 13.06
WRD Yearly Current Assets VS Current LiabilitesWRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

WRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.57%.
WRD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.13%.
The Revenue has been growing by 37.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.5%
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%-64.96%

3.2 Future

Based on estimates for the next years, WRD will show a very strong growth in Earnings Per Share. The EPS will grow by 28.74% on average per year.
Based on estimates for the next years, WRD will show a very strong growth in Revenue. The Revenue will grow by 216.16% on average per year.
EPS Next Y35.27%
EPS Next 2Y28.96%
EPS Next 3Y28.74%
EPS Next 5YN/A
Revenue Next Year73.81%
Revenue Next 2Y137.47%
Revenue Next 3Y216.16%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WRD Yearly Revenue VS EstimatesWRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
WRD Yearly EPS VS EstimatesWRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WRD. In the last year negative earnings were reported.
Also next year WRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRD Price Earnings VS Forward Price EarningsWRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRD Per share dataWRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as WRD's earnings are expected to grow with 28.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.96%
EPS Next 3Y28.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WRD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WERIDE INC-ADR

NASDAQ:WRD (5/22/2025, 8:00:02 PM)

After market: 9.95 -0.13 (-1.29%)

10.08

-0.18 (-1.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-14 2025-03-14
Earnings (Next)N/A N/A
Inst Owners0.82%
Inst Owner Change-15.77%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.77B
Analysts80
Price Target19.38 (92.26%)
Short Float %0.56%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20.86%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.19
P/FCF N/A
P/OCF N/A
P/B 2.82
P/tB 2.85
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.18
BVpS3.57
TBVpS3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.71%
ROE -35.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.66%
FCFM N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.55%
Cap/Sales 23.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.43
Quick Ratio 13.06
Altman-Z 18.52
F-Score3
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)101.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.5%
EPS Next Y35.27%
EPS Next 2Y28.96%
EPS Next 3Y28.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%-64.96%
Revenue Next Year73.81%
Revenue Next 2Y137.47%
Revenue Next 3Y216.16%
Revenue Next 5YN/A
EBIT growth 1Y-39.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25%
OCF growth 3YN/A
OCF growth 5YN/A